BEIJING, March 24, 2026 (GLOBE NEWSWIRE) -- Yimutian Inc. ( YMT ) (the Company) today issued a strategic update to investors and market participants, outlining the Company's capital plan, equity commitments, and financial outlook for 2026. Following a management meeting convened on March 20, 2026, the Board and senior management are setting out, in plain terms, the actions the Company...

LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...

06:40 AM EDT, 03/24/2026 (MT Newswires) -- Gilead Sciences ( GILD ) has agreed to acquire autoimmune disease therapy developer Ouro Medicines for up to $2.18 billion, while the biopharmaceutical firm is in collaboration talks with Galapagos (GLPG) on the assets from the proposed deal. Gilead will pay $1.68 billion in cash for Ouro Medicines as well as up to...

LONDON, March 24 (Reuters) - The estate of late British tech tycoon Mike Lynch was on Tuesday refused permission to appeal a ruling by London's High Court that he was liable to Hewlett Packard Enterprise ( HPE ) over its acquisition of his firm Autonomy. The U.S. technology giant Hewlett Packard ( HPE ) is seeking damages from the estate...